Larry W Moreland

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. pmc A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Arthritis Rheum 64:2824-35. 2012
  2. pmc Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis
    Paula I Burgos
    University of Alabama, Tuscaloosa, Alabama 35487, USA
    Arthritis Res Ther 12:R75. 2010
  3. doi request reprint Cytokines as targets for anti-inflammatory agents
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Ann N Y Acad Sci 1182:88-96. 2009
  4. pmc Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial
    Jeffrey R Curtis
    From the University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Rheumatol 40:572-8. 2013
  5. doi request reprint Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, PA 15261, USA
    Semin Arthritis Rheum 39:132-43. 2009
  6. pmc Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis
    Marshall L R Davis
    Departments of Medicine and Biostatistics, Omaha Veterans Affairs Medical Center VAMC and University of Nebraska Medical Center, Omaha, Nebraska 68198 6270, USA
    J Rheumatol 40:1498-504. 2013
  7. pmc Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis
    Ashutosh Tamhane
    From the University of Alabama at Birmingham, Birmingham, Alabama Emory University, Atlanta, Georgia The University of North Carolina, Chapel Hill, North Carolina The Medical University of South Carolina, Charleston, South Carolina Washington University at St Louis, St Louis, Missouri The University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Rheumatol 40:1812-22. 2013
  8. ncbi request reprint Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis
    Lewis H Kuller
    University of Pittsburgh, Pittsburgh, Pennsylvania
    Arthritis Rheumatol 66:497-507. 2014
  9. pmc Certolizumab pegol: a new biologic targeting rheumatoid arthritis
    Aarat M Patel
    Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children s Hospital, Suite 3000, 400 45th Street, Pittsburgh, PA 15201, USA
    Expert Rev Clin Immunol 6:855-66. 2010

Collaborators

Detail Information

Publications9

  1. pmc A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Arthritis Rheum 64:2824-35. 2012
    ..2 at week 24) to methotrexate (MTX) monotherapy, and to assess whether combination therapy with MTX plus etanercept is superior to the combination of MTX plus sulfasalazine plus hydroxychloroquine...
  2. pmc Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis
    Paula I Burgos
    University of Alabama, Tuscaloosa, Alabama 35487, USA
    Arthritis Res Ther 12:R75. 2010
    ....
  3. doi request reprint Cytokines as targets for anti-inflammatory agents
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Ann N Y Acad Sci 1182:88-96. 2009
    ..These anti-TNF therapies have revolutionized the clinicians' ability to make a significant impact in RA, a disease that has significant excess morbidity and mortality...
  4. pmc Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial
    Jeffrey R Curtis
    From the University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Rheumatol 40:572-8. 2013
    ....
  5. doi request reprint Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms
    Larry W Moreland
    University of Pittsburgh, Pittsburgh, PA 15261, USA
    Semin Arthritis Rheum 39:132-43. 2009
    ..The purpose of this review is to provide a concise appraisal of recent studies investigating the involvement of inflammatory cytokines in the pathogenesis of nonarticular RA manifestations...
  6. pmc Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis
    Marshall L R Davis
    Departments of Medicine and Biostatistics, Omaha Veterans Affairs Medical Center VAMC and University of Nebraska Medical Center, Omaha, Nebraska 68198 6270, USA
    J Rheumatol 40:1498-504. 2013
    ..To investigate the associations of alcohol consumption and radiographic disease progression in African Americans with recently diagnosed rheumatoid arthritis (RA)...
  7. pmc Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis
    Ashutosh Tamhane
    From the University of Alabama at Birmingham, Birmingham, Alabama Emory University, Atlanta, Georgia The University of North Carolina, Chapel Hill, North Carolina The Medical University of South Carolina, Charleston, South Carolina Washington University at St Louis, St Louis, Missouri The University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Rheumatol 40:1812-22. 2013
    ..Studies have reported discordance between DAS28 based on erythrocyte sedimentation rate (ESR) versus C-reactive protein (CRP) in patients with RA. However, such comparison is lacking in African Americans with RA...
  8. ncbi request reprint Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis
    Lewis H Kuller
    University of Pittsburgh, Pittsburgh, Pennsylvania
    Arthritis Rheumatol 66:497-507. 2014
    ..Using these data, we undertook this study to assess total mortality over 10 years of followup among white, black, or Hispanic women with self-reported RA in the WHI...
  9. pmc Certolizumab pegol: a new biologic targeting rheumatoid arthritis
    Aarat M Patel
    Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children s Hospital, Suite 3000, 400 45th Street, Pittsburgh, PA 15201, USA
    Expert Rev Clin Immunol 6:855-66. 2010
    ..Treatment recommendations are beyond the scope of this review; however, with many options available, there will be annotations on current trends in the care of this chronic disease...